Back
Biogen 10K Form
Sell
39
BIIB
Biogen
Last Price:
254.10
Seasonality Move:
16.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BIIB News And Ratings
See the #1 stock for the next 7 days that we like better than BIIB
BIIB Financial Statistics
Sales & Book Value
| Annual Sales: | $10.17B |
|---|---|
| Cash Flow: | $400M |
| Price / Cash Flow: | 32.97 |
| Annual Sales: | $99.91 |
| Price / Book: | 2.55 |
Profitability
| EPS (TTM): | 18.37000 |
|---|---|
| Net Income (TTM): | $2.66B |
| Gross Margin: | $7.9B |
| Return on Equity: | 20.09% |
| Return on Assets: | 10.72% |
Biogen Earnings Forecast
Key Biogen Financial Ratios
- The Gross Profit Margin over the past 39 years for BIIB is 77.61%.
- The Selling, General & Administrative Expenses for BIIB have been equal to 23.63% of Gross Profit Margin.
- The Research & Development expenses have been 21.93% of Revenue.
- The Interest Expense is 8.09% of Operating Income.
- The Net Earning history of BIIB is 29.95% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 27 years.
Biogen Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Drug Manufacturers - General |
| Sector: | Healthcare |
| Current Symbol: | BIIB |
| CUSIP: | 09062X |
| Website: | biogen.com |
Debt
| Debt-to-Equity Ratio: | 0.43 |
|---|---|
| Current Ratio: | 3.27 |
| Quick Ratio: | 2.57 |
Price-to-Earnings
| Trailing P/E Ratio: | 12.22 |
|---|---|
| Forward P/E Ratio: | 15.01 |